Northwest Biotherapeutics Inc (NWBO)
0.30
0.00 (0.00%)
USD |
OTCM |
Nov 14, 10:08
Northwest Biotherapeutics Max Drawdown (5Y): 98.85% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.85% |
| September 30, 2024 | 98.85% |
| August 31, 2024 | 98.85% |
| July 31, 2024 | 98.85% |
| June 30, 2024 | 98.85% |
| May 31, 2024 | 98.85% |
| April 30, 2024 | 98.85% |
| March 31, 2024 | 98.85% |
| February 29, 2024 | 98.85% |
| January 31, 2024 | 98.85% |
| December 31, 2023 | 98.85% |
| November 30, 2023 | 98.85% |
| October 31, 2023 | 98.85% |
| September 30, 2023 | 98.85% |
| August 31, 2023 | 98.85% |
| July 31, 2023 | 98.85% |
| June 30, 2023 | 98.85% |
| May 31, 2023 | 98.85% |
| April 30, 2023 | 98.85% |
| March 31, 2023 | 98.85% |
| February 28, 2023 | 98.85% |
| January 31, 2023 | 98.85% |
| December 31, 2022 | 98.85% |
| November 30, 2022 | 98.85% |
| October 31, 2022 | 98.85% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.85% |
| August 31, 2022 | 98.85% |
| July 31, 2022 | 98.85% |
| June 30, 2022 | 98.85% |
| May 31, 2022 | 98.85% |
| April 30, 2022 | 98.85% |
| March 31, 2022 | 98.85% |
| February 28, 2022 | 98.85% |
| January 31, 2022 | 98.85% |
| December 31, 2021 | 98.85% |
| November 30, 2021 | 98.85% |
| October 31, 2021 | 98.85% |
| September 30, 2021 | 98.85% |
| August 31, 2021 | 98.85% |
| July 31, 2021 | 98.85% |
| June 30, 2021 | 98.85% |
| May 31, 2021 | 98.85% |
| April 30, 2021 | 98.85% |
| March 31, 2021 | 98.85% |
| February 28, 2021 | 98.85% |
| January 31, 2021 | 98.85% |
| December 31, 2020 | 98.85% |
| November 30, 2020 | 98.85% |
| October 31, 2020 | 98.85% |
| September 30, 2020 | 98.85% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.84%
Minimum
Nov 2019
98.85%
Maximum
Mar 2020
98.85%
Average
98.85%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 7.553 |
| Beta (5Y) | -0.5489 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 107.6% |
| Historical Sharpe Ratio (5Y) | 0.0043 |
| Historical Sortino (5Y) | 0.0145 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.23% |